A wearable stethoscope may let kids with asthma monitor their lungs at home
NCT ID NCT07792330
First seen Aug 28, 2026 · Last updated Aug 28, 2026
Summary
Researchers at Children's Hospital Los Angeles are testing a prototype wearable stethoscope that records lung sounds in children and adolescents with asthma aged 4 to 17. The study compares the device's recordings with those from a standard digital stethoscope to see if it can accurately detect abnormal lung sounds and changes after bronchodilator treatment. The goal is to determine whether the wearable device can help assess asthma control and potentially offer a convenient way to monitor the condition.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- A prototype wearable stethoscope, a wireless device that records lung sounds in children with asthma
- What this could lead to
- If it works, this could lead to a simple, wearable way to monitor asthma control at home and catch changes early.
- What could go wrong
- This is an early, small study of 50 children, and the device may not match the accuracy of standard stethoscopes or reliably reflect asthma control.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Oct 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
4 to 17 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Children and adolescents aged 4 to 17 years * Diagnosis of asthma * Ability to perform spirometry * Assent (as applicable) and parental/legal guardian permission obtained Exclusion Criteria: * Unable to follow spirometry procedures * Intubated at the time of enrollment
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Airway obstruction upper are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Children's Hospital Los Angeles
Los Angeles, California, 90027, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single triple inhaler tame asthma in the real world?
- Can a Three-Drug inhaler outperform the standard Two-Drug treatment for asthma?
- Can a school program tame childhood asthma in san juan?
- Can a new inhaler match Symbicort's performance?
- Smart spacer device aims to fix Kids' inhaler mistakes
- Fine-Mist inhalers aim to reach deep lungs in COPD